Redhill Biopharma Statistics
NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.281-0.0423 (-13.08%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Redhill Biopharma by the numbers
Redhill Biopharma has a market capitalization of $2.5 million based on 8.89M shares outstanding. With trailing EPS of $0.00, Redhill Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.4% below its 50-day average and 62.3% below its 200-day average.
Average daily trading volume is 2.08M shares, or about $584,657 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RDHL valuation vs. peer median
| Metric | RDHL | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.50M | $2.41M | +4% |
| Avg. volume | 2.08M | 396.14K | +425% |
Peer median across 8 companies: DRMA, GRI, ONCO, HCWB, MBIO, TRAW, ERNA, LABT.
Valuation
- Market cap
- $2.50M
- Forward P/E
- 9.37
- Price / sales (latest FY)
- 0.31
- EPS (TTM)
- $0.00
- Shares outstanding
- 8.89M
Price and trading
- Previous close
- 0.3233
- Open
- 0.3114
- Day range
- 0.281 – 0.3385
- 52-week range
- 0.281 – 1.60
- 50-day moving average
- 0.4636
- 200-day moving average
- 0.7452
- Beta
- —
- Volume
- 24.25K
- Average volume
- 2.08M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 10, 2025
Additional statistics
- Market Cap
- 2.50M
- Forward Pe
- 9.37
- Eps
- 0.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.60
- Week52 Low
- 0.28
- Avg Volume
- 2.08M
- Shares Outstanding
- 8.89M
- Ma50
- 0.46
- Ma200
- 0.75
- Earnings Date
- Apr 10, 2025
- Pct From52w High
- -82.44%
- Pct From52w Low
- 0.00%